Hemp Bombs CBD Pain Freeze Recalled Due to Subpotent Menthol Content
Hemp Bombs CBD Pain Freeze is being recalled because the menthol potency is less than the labeled 4%. Consumers should stop using the affected product and return it to the retailer.
The agency’s classification
FDA (Drugs): Class III
Class III is a situation in which use of or exposure to a violative product is not likely to cause adverse health consequences.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 2/5 (Moderate).
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: FDA Class III recall for subpotency in a drug product. The menthol content is below the labeled 4%. This potency mislabeling warrants Score 2 (Moderate) per the rubric's guidance that Class III recalls are typically scored 1 or 2.
Plain-English summary
Hemp Bombs CBD Pain Freeze is being recalled. The product is a menthol 4% topical pain relief cream in 1 oz bottles, manufactured by Global Widget LLC and distributed from 8419 Sunstate St, Tampa, Florida.
The recall is due to subpotency: the active ingredient (menthol) is less than the label claim of 4%. This means the product does not contain the amount of menthol consumers expect based on the label.
The affected products are distributed nationwide. The specific lot numbers involved are: Lot 230189 (expires April 2025), Lot 230335 (expires July 2025), and Lot 230351 (expires August 2025). Approximately 18,540 bottles are affected. The product has NDC 73423-003-01 and UPC 8-40078-56493-2.
Consumers who have this product should stop using it and discard it or return it to the retailer.
The recalled product
- Product
- Hemp Bombs CBD Pain Freeze (menthol 4%), 100mg, 1 oz bottles, Distributed by: Global Widget 8419 Sunstate St, Tampa FL 33634, NDC 73423-003-01; UPC Code: 8-40078-56493-2
- Manufacturer
- GLOBAL WIDGET LLC
- Category
- Drug — Topical / Pain Relief
- Hazard
- Affected units
- 18,540
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (6)
- Lot #: 230189
- Exp. date Apr 2025
- 230335
- Exp. date Jul 2025
- 230351
- Exp. date Aug 2025
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 4 recalled by GLOBAL WIDGET LLC under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 4 products in this recall →Related recalls
Same manufacturer · GLOBAL WIDGET LLC
See all →- ModerateNature's Script CBD Pain Relief Roll-On Recalled for Subpotent Menthol
FDA (Drugs) · 2024-07-31
- ModerateHemp Bombs CBD Pain Freeze Recalled Due to Subpotent Menthol Content
FDA (Drugs) · 2024-07-31
- ModerateHemp Bombs CBD Pain Freeze Recalled for Subpotent Menthol Content
FDA (Drugs) · 2024-07-31
Same hazard · subpotency
See all →- ModerateGood Neighbor Pharmacy Earwax Removal Drug Recalled for Low Potency
FDA (Drugs) · 2026-07-22
- ModerateNystatin Cream Recall Due to Low Potency Test Results
FDA (Drugs) · 2026-07-22
- ModerateFoster & Thrive Carbamide Peroxide 6.5% Recalled for Subpotent Strength
FDA (Drugs) · 2026-07-22
- ModerateLeader Carbamide Peroxide Earwax Removal Kit Recalled for Subpotency
FDA (Drugs) · 2026-07-22
- ModerateMeijer Earwax Removal Kit Recalled for Subpotent Active Ingredient
FDA (Drugs) · 2026-07-22
Similar recalls
- ModerateUS Pharmaceuticals Recalls Wonder Freeze Pain Gel Due to Water Quality Issues
FDA (Drugs) · 2019-08-21
- ModerateMenthol pain relief gel recalled over manufacturing practice deviations
FDA (Drugs) · 2025-12-03
- SevereIdeaz Recalls Screamin' Menthol Pain Gel Due to Benzene Levels
FDA (Drugs) · 2018-05-30
- ModerateMedtech Recalls Little Remedies For Tummys Laxative Drops for Subpotency
FDA (Drugs) · 2012-09-12
- LowAmerican Health Packaging Recalls Subpotent Methylprednisolone Tablets
FDA (Drugs) · 2014-10-29
- ModerateQualitest Recalls Subpotent Methylprednisolone Tablets Due to Stability Issues
FDA (Drugs) · 2014-10-01